Annual Working Capital
$174.15 M
-$64.38 M-26.99%
December 31, 2022
Summary
- As of February 9, 2025, TALS annual working capital is $174.15 million, with the most recent change of -$64.38 million (-26.99%) on December 31, 2022.
- During the last 3 years, TALS annual working capital has risen by +$135.65 million (+352.31%).
Performance
TALS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$146.07 M
-$12.61 M-7.95%
June 30, 2023
Summary
- As of February 9, 2025, TALS quarterly working capital is $146.07 million, with the most recent change of -$12.61 million (-7.95%) on June 30, 2023.
- Over the past year, TALS quarterly working capital has dropped by -$58.63 million (-28.64%).
Performance
TALS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TALS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.0% | -28.6% |
| 3 y3 years | +352.3% | - |
| 5 y5 years | +352.3% | - |
TALS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.0% | at low | -38.8% | at low |
| 5 y | 5-year | -27.0% | -77.9% | -45.0% | -4.7% |
| alltime | all time | -27.0% | -77.9% | -45.0% | -4.7% |
Talaris Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $146.07 M(-7.9%) |
| Mar 2023 | - | $158.68 M(-8.9%) |
| Dec 2022 | $174.15 M(-27.0%) | $174.15 M(-7.8%) |
| Sep 2022 | - | $188.96 M(-7.7%) |
| Jun 2022 | - | $204.71 M(-7.1%) |
| Mar 2022 | - | $220.35 M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $238.53 M(+61.9%) | $238.53 M(-5.8%) |
| Sep 2021 | - | $253.25 M(-4.7%) |
| Jun 2021 | - | $265.81 M(+90.9%) |
| Mar 2021 | - | $139.22 M(-5.5%) |
| Dec 2020 | $147.35 M(+282.7%) | - |
| Dec 2020 | - | $147.35 M |
| Dec 2019 | $38.50 M | - |
FAQ
- What is Talaris Therapeutics annual working capital?
- What is the all time high annual working capital for Talaris Therapeutics?
- What is Talaris Therapeutics annual working capital year-on-year change?
- What is Talaris Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Talaris Therapeutics?
- What is Talaris Therapeutics quarterly working capital year-on-year change?
What is Talaris Therapeutics annual working capital?
The current annual working capital of TALS is $174.15 M
What is the all time high annual working capital for Talaris Therapeutics?
Talaris Therapeutics all-time high annual working capital is $238.53 M
What is Talaris Therapeutics annual working capital year-on-year change?
Over the past year, TALS annual working capital has changed by -$64.38 M (-26.99%)
What is Talaris Therapeutics quarterly working capital?
The current quarterly working capital of TALS is $146.07 M
What is the all time high quarterly working capital for Talaris Therapeutics?
Talaris Therapeutics all-time high quarterly working capital is $265.81 M
What is Talaris Therapeutics quarterly working capital year-on-year change?
Over the past year, TALS quarterly working capital has changed by -$58.63 M (-28.64%)